AUA

Shorts

Jenny N. Guo, MD, on key BPH takeaways from AUA 2026
0:36
Jenny N. Guo, MD, on key BPH takeaways from AUA 2026
5 months ago
by
Jenny N. Guo, MD
Kari A.O. Tikkinen, MD, PhD, discusses tranexamic acid in urology
0:33
Kari A.O. Tikkinen, MD, PhD, discusses tranexamic acid in urology
6 months ago
by
Kari A.O. Tikkinen, MD, PhD
Nicole L. Miller, MD, FACS, on advances in evaluating and treating LUTS
1:38
Nicole L. Miller, MD, FACS, on advances in evaluating and treating LUTS
6 months ago
by
Nicole L. Miller, MD, FACS
Catherine A. Matthews, MD, FACS, shares takeaways from the INTIBIA Pivotal Trial
0:32
Catherine A. Matthews, MD, FACS, shares takeaways from the INTIBIA Pivotal Trial
6 months ago
by
Catherine A. Matthews, MD, FACOG, FACS, FPMRS
Michael S. Cookson, MD, on darolutamide’s safety profile
0:22
Michael S. Cookson, MD, on darolutamide’s safety profile
6 months ago
by
Michael S. Cookson, MD, MMHC, FACS
Jonathan D. Harper, MD, on increasing fluid intake to prevent recurrent stones
0:41
Jonathan D. Harper, MD, on increasing fluid intake to prevent recurrent stones
6 months ago
by
Jonathan D. Harper, MD
Nima Almassi, MD, on shared decision-making around bladder-preserving treatment options
0:57
Nima Almassi, MD, on shared decision-making around bladder-preserving treatment options
6 months ago
by
Nima Almassi, MD
Kathryn H. Gessner, MD, PhD, on the most exciting current developments in bladder cancer
0:49
Kathryn H. Gessner, MD, PhD, on the most exciting current developments in bladder cancer
6 months ago
by
Kate Gessner, MD, PhD
Joshua J. Meeks, MD, PhD, on the need for recombinant BCG
0:18
Joshua J. Meeks, MD, PhD, on the need for recombinant BCG
6 months ago
by
Joshua J. Meeks, MD, PhD
Nicole L. Miller, MD, FACS, on what she tells patients after BPH treatment failure
0:39
Nicole L. Miller, MD, FACS, on what she tells patients after BPH treatment failure
6 months ago
by
Nicole L. Miller, MD, FACS

Latest Content

Rymden - stock.adobe.com

Misinformation about prostate cancer is rampant online and significantly impacts patient care, study authors said at an American Urological Association press briefing. Researchers using machine learning have taken what they say is a first step to help vet the quality of online content.

whyframeshot - stock.adobe.com

The benefits of minimally invasive water vapor thermal therapy (Rezūm System) on lower urinary tract symptoms due to benign prostatic hyperplasia are durable, with a reduction in symptom score and an improvement in flow rate sustained to 5 years, according to researchers.

Data from a large registry showed that active surveillance for small renal masses was safe and noninferior to primary intervention at 10 years. In this video, senior author Phillip M. Pierorazio, MD, of Johns Hopkins University discusses results of the study presented as part of the AUA 2020 Virtual Experience.